BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 21955560)

  • 1. [Partial elective nephrectomy].
    Zungri E; Martínez L; Leal D; Lorenzo L
    Actas Urol Esp; 2012 Mar; 36(3):160-4. PubMed ID: 21955560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Pahernik S; Roos F; Röhrig B; Wiesner C; Thüroff JW
    J Urol; 2008 Jan; 179(1):71-4; discussion 74. PubMed ID: 17997423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.
    Gofrit ON; Shapiro A; Kovalski N; Landau EH; Shenfeld OZ; Pode D
    Eur Urol; 2001 Jun; 39(6):669-74; discussion 675. PubMed ID: 11464056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncological outcomes of nephron sparing nephrectomy. 17-year analysis.
    Aguilera Bazan A; Bañuelos B; Alonso-Dorrego JM; Diez J; Cisneros J; De la Peña Barthel J
    Arch Esp Urol; 2014 Apr; 67(3):237-42. PubMed ID: 24840588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robotic partial nephrectomy with selective parenchymal compression (Simon clamp).
    Castillo OA; Rodriguez-Carlin A; Lopez-Fontana G; Aleman E
    Actas Urol Esp; 2013; 37(7):425-8. PubMed ID: 23433637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery.
    Morgan MA; Roberts NR; Pino LA; Trabulsi EJ; Brown DB; Gomella LG; Lallas CD
    Can J Urol; 2013 Oct; 20(5):6933-7. PubMed ID: 24128832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic partial nephrectomy for incidental stage pT2 or worse tumors.
    Ukimura O; Haber GP; Remer EM; Gill IS
    Urology; 2006 Nov; 68(5):976-82. PubMed ID: 17095068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-operative imaging may overestimate the kidney tumor size.
    Nasseh HR; Falahatkar S; Ghanbari A; Bagheri Chenari H
    Urol J; 2012; 9(4):662-6. PubMed ID: 23235970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation surgery in patients with localized renal cell cancer--nephron sparing surgery.
    Djozić J; Djozić S; Bogdanović J; Sekulić V; Djozić M; Vojinov S; Levakov I; Zivojinov S; Jeremić D; Marušić G; Djozić D
    Acta Chir Iugosl; 2014; 61(1):45-9. PubMed ID: 25782225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.
    Belldegrun A; Tsui KH; deKernion JB; Smith RB
    J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of nephron-sparing surgery for the treatment of renal cell carcinoma 4 to 7 cm in size.
    Pertia A; Managadze L; Chkhotua A
    Georgian Med News; 2012 Nov; (212):7-12. PubMed ID: 23221132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative predictors of surgical approach for partial nephrectomy.
    Raman JD; Smith B; Messer J; Rohner TJ; Harpster LE; Reese CT
    Can J Urol; 2011 Oct; 18(5):5896-902. PubMed ID: 22018152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predictors of benign lesions in renal masses smaller than 7 cm presumed to be renal cell carcinoma.
    Akdogan B; Gudeloglu A; Inci K; Gunay LM; Koni A; Ozen H
    Clin Genitourin Cancer; 2012 Jun; 10(2):121-5. PubMed ID: 22401753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephron-sparing surgery across a nation - outcomes from the British Association of Urological Surgeons 2012 national partial nephrectomy audit.
    Fernando A; Fowler S; O'Brien T;
    BJU Int; 2016 Jun; 117(6):874-82. PubMed ID: 26469291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of arterial occlusion during partial nephrectomy on residual renal function: an evaluation with (99m)technetium-dimercaptosuccinic acid scintigraphy.
    Kondo T; Nakazawa H; Ito F; Onitsuka S; Ryoji O; Yago R; Hashimoto Y; Toma H
    Int J Urol; 2002 Aug; 9(8):435-40. PubMed ID: 12225340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding indication for elective nephron-sparing surgery in renal cell carcinoma.
    Ficarra V; Secco S; Fracalanza S; Novara G; Gidaro S; Cindolo L; Schips L
    Arch Ital Urol Androl; 2009 Jun; 81(2):86-90. PubMed ID: 19760862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robot-assisted laparoscopic nephron sparing surgery for tumors over 4 cm: operative results and preliminary oncologic outcomes from a multicentre French study.
    Masson-Lecomte A; Yates DR; Bensalah K; Vaessen C; de la Taille A; Roumiguié M; Doumerc N; Bruyère F; Soustelle L; Droupy S; Rouprêt M
    Eur J Surg Oncol; 2013 Jul; 39(7):799-803. PubMed ID: 23566551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.